Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps

QR Code

Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps

After more than a decade of intense investigation, Pro-protein Convertase Subtilisin-Kexin type 9 (PCSK9) remains a hot topic of research both at experimental and clinical level. Interestingly PCSK9 is expressed in different tissues suggesting the existence of additional function(s) beyond the modul...

Full description

Bibliographic Details
Main Authors:	Baragetti, A., Grejtakova, D., Casula, M., Olmastroni, E., Jotti, G., Norata, Giuseppe, Catapano, A., Bellosta, S.
Format:	Journal Article
Published:	Academic Press 2018
Online Access:	http://hdl.handle.net/20.500.11937/66848

Similar Items

Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure-function relation to therapeutic inhibition
by: Tibolla, G., et al.
Published: (2011)

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)

Targeting PCSK9 for hypercholesterolemia
by: Norata, Giuseppe, et al.
Published: (2014)

PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)

PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges
by: Norata, Giuseppe, et al.
Published: (2014)

PCSK9 inhibitors and dyslipidemia: The clinical evidence
by: Norata, Giuseppe
Published: (2014)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)

PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans
by: Baragetti, A., et al.
Published: (2017)

In vivo and in vitro effects of phaleria macrocarpa (scheff.) boerl on low density lipoprotein and pcsk9 expression
by: Chong, Soo Ching
Published: (2011)

Squaring up the health economics of PCSK9 monoclonal antibodies ‘down under’
by: Watts, G., et al.
Published: (2018)

Markers of Triglyceride-rich Lipoprotein Remnant Metabolism in Visceral Obesity
by: Chan, D., et al.
Published: (2002)

Phaleria macrocarpa (Scheff.) Boerl fruit aqueous extract enhances LDL receptor and PCSK9 expression in vivo and in vitro.
by: Chong, Soo Ching, et al.
Published: (2011)

High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)

High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)

High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013)

Association Of Single Nucleotide Polymorphisms (Snp) In Pcsk9 Gene With Lipid Analysis Among Iban And Bidayuh Ethnic Groups In Sarawak Population.
by: H. H., Hood, et al.
Published: (2015)

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)

MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
by: Norata, Giuseppe, et al.
Published: (2013)

Versatility of subtilisin: a review on structure, characteristics, and applications
by: Mohd Azrin, Nur Aliyah, et al.
Published: (2022)

PCSK9 inhibitory activity of marine-derived compounds, aaptaminoids, and benzamide originated from Aaptos aaptos and Acanthaster planci as a potential treatment for atherosclerosis.
by: Habsah, Mohamad, et al.
Published: (2020)

Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)

Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome
by: Irawati, D., et al.
Published: (2016)

Detection Of Triglyceride Based On Microwave Dielectric Properties Of Triglyceride Enzymatic Reaction
by: Hamid, Hasnidar
Published: (2010)

Mutagenic study of benzimidazole derivatives with (+S9) and without (−S9) metabolic activation
by: Azahar, Nurul Hafizan, et al.
Published: (2019)

9-Benzyl-6-benzylsulfanyl-9H-purin-2-amine
by: Hariono, Maywan, et al.
Published: (2014)

The myth of 9/11
by: Formby, Zoë
Published: (2011)

Bab 9: Ingatan
by: Yahaya, Azizi, et al.
Published: (2005)

Bab 9: Ingatan
by: Yahaya, Azizi, et al.
Published: (2005)

Host defence peptide (HDP) human beta defensin 9 (HBD9)
by: Omar, Nazri
Published: (2016)

Lipoprotein ontology: a formal representation of Lipoproteins
by: Kohn, Meifania Monica
Published: (2013)

9 Sekeluarga bergraduasi serentak
by: UMP, PNC
Published: (2019)

E-Citra Artwork9
by: Halim, H.
Published: (2014)

Semua 9A+ layak
by: Berita harian, Nazura Ngah
Published: (2010)

Pengumuman dari Chanel 9
by: Universiti Putra Malaysia, Bahagian Komunikasi Korporat
Published: (2010)

9,010 receive scholarships
by: Kannan, Hashini Kavishtri
Published: (2016)

Bab 9 : Pemikiran kritikal
by: Hashim, Shahrin
Published: (2010)

Aug 9, 2012 bronze, Aug 9, 2016 silver Aug, 17 2016 gold?
by: The Star,
Published: (2016)

The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
by: Ammirati, E., et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9uslaaipj9l5nrcrgg5e246qr7